{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:14:57Z","timestamp":1790781297137,"version":"4.1.0"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec id=\"ab-erv230001-4\"><jats:title>Importance<\/jats:title><jats:p>Dry eye is a common ocular disease that can have substantial morbidity. Systematic reviews provide evidence for dry eye interventions and can be useful for patients, clinicians, and clinical guideline developers. Overviews of reviews use explicit and systematic methods to synthesize findings from multiple systematic reviews, but currently, there are no overviews of systematic reviews investigating interventions for dry eye.<\/jats:p><\/jats:sec><jats:sec id=\"ab-erv230001-5\"><jats:title>Objective<\/jats:title><jats:p>To summarize the results of reliable systematic reviews of dry eye interventions and to highlight the evidence gaps identified.<\/jats:p><\/jats:sec><jats:sec id=\"ab-erv230001-6\"><jats:title>Evidence Review<\/jats:title><jats:p>We searched the Cochrane Eyes and Vision US satellite database and included reliable systematic reviews evaluating dry eye interventions published from 2016 to 2022. We reported the proportion of systematic reviews that were reliable with reasons for unreliability. Critical and important outcomes from reliable systematic reviews were extracted and verified. Critical outcomes included dry eye\u2013related patient-reported outcome measures. Results were synthesized from reliable systematic reviews to provide summaries of evidence for each intervention. Evidence for each intervention was defined as conclusive or inconclusive depending on whether high-certainty evidence across systematic reviews was available according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) criteria and whether findings reached statistical or clinical significance. Recommendations were made for further research.<\/jats:p><\/jats:sec><jats:sec id=\"ab-erv230001-7\"><jats:title>Findings<\/jats:title><jats:p>Within the Cochrane Eyes and Vision US satellite database, 138 potentially relevant systematic reviews were identified, 71 were considered eligible, and 26 (37%) were assessed as reliable. Among reliable systematic reviews, no conclusive evidence was identified for any dry eye intervention. Inconclusive evidence suggested that environmental modifications, dietary modifications, artificial tears and lubricants, punctal occlusion, intense pulsed light therapy, vectored thermal pulsation therapy (Lipiflow), topical corticosteroids, topical cyclosporine A, topical secretagogues, and autologous serum may be effective. Only unreliable systematic reviews evaluated lifitegrast, oral antibiotics, and moisture chamber devices.<\/jats:p><\/jats:sec><jats:sec id=\"ab-erv230001-8\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This overview of systematic reviews found some evidence that dry eye interventions may be effective, but no conclusive evidence was available. The conduct and reporting of most systematic reviews for dry eye interventions warrant improvement, and reliable systematic reviews are needed to evaluate lifitegrast, oral antibiotics, and moisture chamber devices.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2023.5751","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:01:28Z","timestamp":1703174488000},"page":"58","source":"Crossref","is-referenced-by-count":36,"title":["Interventions for Dry Eye"],"prefix":"10.1001","volume":"142","author":[{"given":"Paul","family":"McCann","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanna","family":"Kruoch","sequence":"additional","affiliation":[{"name":"College of Optometry, Rocky Mountain University of Health Professions, Provo, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lopez","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Malli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Epidemiology, Colorado School of Public Health, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Epidemiology, Colorado School of Public Health, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"erv230001r1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report.","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"erv230001r2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life.","volume":"143","author":"Miljanovic","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"erv230001r3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis.","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"issue":"1","key":"erv230001r4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ophtha.2018.10.023","article-title":"Dry Eye Syndrome Preferred Practice Pattern\u00ae.","volume":"126","author":"Akpek","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"erv230001r5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report.","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"7","key":"erv230001r7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamaophthalmol.2019.1063","article-title":"Reliability of the evidence addressing treatment of corneal diseases: a summary of systematic reviews.","volume":"137","author":"Saldanha","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"erv230001r9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13643-018-0784-8","article-title":"Toward a comprehensive evidence map of overview of systematic review methods: paper 2-risk of bias assessment; synthesis, presentation and summary of the findings; and assessment of the certainty of the evidence.","volume":"7","author":"Lunny","year":"2018","journal-title":"Syst Rev"},{"issue":"1","key":"erv230001r10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13643-017-0617-1","article-title":"Toward a comprehensive evidence map of overview of systematic review methods: paper 1-purpose, eligibility, search and data extraction.","volume":"6","author":"Lunny","year":"2017","journal-title":"Syst Rev"},{"key":"erv230001r11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ"},{"issue":"4","key":"erv230001r12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-147-4-200708210-00179","article-title":"How quickly do systematic reviews go out of date? a survival analysis.","volume":"147","author":"Shojania","year":"2007","journal-title":"Ann Intern Med"},{"issue":"12","key":"erv230001r13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jclinepi.2014.08.008","article-title":"Up-to-dateness of reviews is often neglected in overviews: a systematic review.","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"erv230001r15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jclinepi.2021.10.023","article-title":"Harms in systematic reviews paper 1: an introduction to research on harms.","volume":"143","author":"Qureshi","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"erv230001r16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaophthalmol.2018.3352","article-title":"Research questions and outcomes prioritized by patients with dry eye.","volume":"136","author":"Saldanha","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"erv230001r17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA).","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"4","key":"erv230001r18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41433-021-01514-0","article-title":"Development and content of a database of systematic reviews for eyes and vision.","volume":"36","author":"L\u00ea","year":"2022","journal-title":"Eye (Lond)"},{"issue":"1","key":"erv230001r20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12886-017-0561-9","article-title":"The quality of systematic reviews about interventions for refractive error can be improved: a review of systematic reviews.","volume":"17","author":"Mayo-Wilson","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"erv230001r21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ogla.2021.01.007","article-title":"What do we really know about the effectiveness of glaucoma interventions? an overview of systematic reviews.","volume":"4","author":"Qureshi","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"erv230001r22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamaophthalmol.2018.0786","article-title":"Identification and description of reliable evidence for 2016 American Academy of Ophthalmology preferred practice pattern guidelines for cataract in the adult eye.","volume":"136","author":"Golozar","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"erv230001r23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/jamaophthalmol.2019.4016","article-title":"Evaluation of systematic reviews of interventions for retina and vitreous conditions.","volume":"137","author":"Le","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"erv230001r24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.oret.2023.03.009","article-title":"All that glitters is not gold: interpreting systematic reviews and meta-analyses with case studies from ophthalmology, part one.","volume":"7","author":"Downie","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"erv230001r25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jrsm.v11.3","article-title":"Adjudication rather than experience of data abstraction matters more in reducing errors in abstracting data in systematic reviews.","volume":"11","author":"E","year":"2020","journal-title":"Res Synth Methods"},{"issue":"1","key":"erv230001r26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13643-019-1250-y","article-title":"The Systematic Review Data Repository (SRDR): descriptive characteristics of publicly available data and opportunities for research.","volume":"8","author":"Saldanha","year":"2019","journal-title":"Syst Rev"},{"issue":"7651","key":"erv230001r27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"erv230001r28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2288-9-16","article-title":"Building blocks for meta-synthesis: data integration tables for summarising, mapping, and synthesising evidence on interventions for communicating with health consumers.","volume":"9","author":"Ryan","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"erv230001r29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions.","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"erv230001r30","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/ICO.0000000000001350","article-title":"Gaps in current knowledge and priorities for future research in dry eye.","volume":"36","author":"Saldanha","year":"2017","journal-title":"Cornea"},{"issue":"3","key":"erv230001r31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jrsm.v13.3","article-title":"Graphical Representation of Overlap for OVErviews: GROOVE tool.","volume":"13","author":"P\u00e9rez-Bracchiglione","year":"2022","journal-title":"Res Synth Methods"},{"issue":"12","key":"erv230001r32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012219.pub2","article-title":"Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace.","volume":"12","author":"Byber","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"erv230001r33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009729.pub2","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome.","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"erv230001r34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5935\/0004-2749.20190097","article-title":"Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.","volume":"82","author":"Ribeiro","year":"2019","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"erv230001r35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/ICO.0000000000001884","article-title":"Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials.","volume":"38","author":"Giannaccare","year":"2019","journal-title":"Cornea"},{"issue":"5","key":"erv230001r36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/nu11050942","article-title":"Effects of polyunsaturated fatty acids on nonspecific typical dry eye disease: a systematic review and meta-analysis of randomized clinical trials.","volume":"11","author":"Chi","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"erv230001r37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011016.pub2","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.","volume":"12","author":"Downie","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"erv230001r38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ophtha.2022.05.009","article-title":"Interventions for the management of computer vision syndrome: a systematic review and meta-analysis.","volume":"129","author":"Singh","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"erv230001r39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Punctal occlusion for dry eye syndrome.","volume":"6","author":"Ervin","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"erv230001r40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013559","article-title":"Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.","volume":"3","author":"Cote","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"erv230001r41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/ICO.0000000000001907","article-title":"Efficacy of vectored thermal pulsation and warm compress treatments in meibomian gland dysfunction: a meta-analysis of randomized controlled trials.","volume":"38","author":"Pang","year":"2019","journal-title":"Cornea"},{"issue":"10","key":"erv230001r42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015070.pub2","article-title":"Topical corticosteroids for dry eye.","volume":"10","author":"Liu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"erv230001r43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010051.pub2","article-title":"Topical cyclosporine A therapy for dry eye syndrome.","volume":"9","author":"de Paiva","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"erv230001r44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/DDDT","article-title":"An updated systematic review with meta-analysis of randomized trials on topical cyclosporin A for dry-eye disease.","volume":"14","author":"Tuan","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"erv230001r45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/ICO.0000000000002943","article-title":"Short-term efficacy and safety of biological tear substitutes and topical secretagogues for dry eye disease: a systematic review and network meta-analysis.","volume":"41","author":"Jongkhajornpong","year":"2022","journal-title":"Cornea"},{"issue":"2","key":"erv230001r46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009327.pub3","article-title":"Autologous serum eye drops for dry eye.","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"erv230001r47","first-page":"200","article-title":"Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"},{"issue":"5","key":"erv230001r48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000505630","article-title":"Autologous serum eye drops versus artificial tear drops for dry eye disease: a systematic review and meta-analysis of randomized controlled trials.","volume":"63","author":"Wang","year":"2020","journal-title":"Ophthalmic Res"},{"issue":"8","key":"erv230001r49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/GME.0000000000001559","article-title":"The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.","volume":"27","author":"Hao","year":"2020","journal-title":"Menopause"},{"issue":"9","key":"erv230001r50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1507\/endocrj.EJ20-0178","article-title":"The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies.","volume":"67","author":"Wang","year":"2020","journal-title":"Endocr J"},{"key":"erv230001r51","first-page":"1690","article-title":"Pranoprofen eye drops in the treatment of dry eye disease: a systematic review\/meta-analysis.","volume":"27","author":"Zhou","year":"2018","journal-title":"Zhongguo Xin Yao Zazhi"},{"issue":"3","key":"erv230001r52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150749","article-title":"Rituximab effectiveness and safety for treating primary Sj\u00f6gren\u2019s syndrome (pSS): systematic review and meta-analysis.","volume":"11","author":"Souza","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"erv230001r53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2017.06.004","article-title":"Efficacy and safety of biological DMARDs modulating B cells in primary Sj\u00f6gren\u2019s syndrome: systematic review and meta-analysis.","volume":"85","author":"Letaief","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"7","key":"erv230001r54","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/acr.v72.7","article-title":"Meta-analysis of treatment for primary Sj\u00f6gren\u2019s syndrome.","volume":"72","author":"Chu","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"erv230001r55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12906-018-2202-0","article-title":"Optimizing acupuncture treatment for dry eye syndrome: a systematic review.","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"erv230001r56","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fphar.2020.00580","article-title":"The efficacy and safety of qiming granule for dry eye disease: a systematic review and meta-analysis.","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"5","key":"erv230001r57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/aos.v99.5","article-title":"Therapeutic effects of acupuncture in typical dry eye: a systematic review and meta-analysis.","volume":"99","author":"Na","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"erv230001r58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/jop.2009.0091","article-title":"Topical cyclosporine 0.05% for the prevention of dry eye disease progression.","volume":"26","author":"Rao","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"erv230001r59","first-page":"1769","article-title":"Efficacy and safety of lifitegrast in the treatment of dry eye disease: a meta-analysis.","volume":"20","author":"Li","year":"2020","journal-title":"Int Eye Sci"},{"key":"erv230001r60","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2174\/1874364101711010346","article-title":"Therapies for meibomian gland dysfunction: a systematic review and meta-analysis of randomized controlled trials.","volume":"11","author":"Sridharan","year":"2017","journal-title":"Open Ophthalmol J"},{"issue":"10","key":"erv230001r61","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41433-020-0876-2","article-title":"Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin.","volume":"34","author":"Tao","year":"2020","journal-title":"Eye (Lond)"},{"issue":"5","key":"erv230001r62","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/aos.v100.5","article-title":"Chambered warm moist air eyelid warming devices: a review.","volume":"100","author":"Magno","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"erv230001r63","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/cxo.13035","article-title":"Non-pharmaceutical treatment options for meibomian gland dysfunction.","volume":"103","author":"Arita","year":"2020","journal-title":"Clin Exp Optom"},{"issue":"18","key":"erv230001r64","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 Fatty acid supplementation for the treatment of dry eye disease.","volume":"378","author":"Asbell","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"erv230001r65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015448","article-title":"LipiFlow for the treatment of dry eye disease.","author":"Pucker","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"erv230001r66","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/OPX.0000000000002042","article-title":"Autologous serum eye drops for dry eye: systematic review.","volume":"100","author":"Quan","year":"2023","journal-title":"Optom Vis Sci"},{"issue":"1","key":"erv230001r67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"erv230001r68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement.","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"erv230001r69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ajo.2023.03.008","article-title":"NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE Study.","volume":"252","author":"Sheppard","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"erv230001r70","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI Study.","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"issue":"9","key":"erv230001r71","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","article-title":"A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease.","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"erv230001r72","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease: the ONSET-2 phase 3 randomized trial.","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"key":"erv230001r6","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine","year":"2011"},{"key":"erv230001r8","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019","edition":"2nd ed"},{"key":"erv230001r14","volume-title":"Finding What Works in Health Care: Standards for Systematic Reviews","author":"Institute of Medicine (IOM)","year":"2011"},{"key":"erv230001r19","unstructured":"Veritas Health Innovation Melbourne Australia. Covidence systematic review software. Accessed November 7, 2023. https:\/\/www.covidence.org"},{"key":"erv230001r73","unstructured":"US Food and Drug Administration. Dry eye: developing drugs for treatment guidance for industry. Accessed October 16, 2023. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/dry-eye-developing-drugs-treatment-guidance-industry"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2812947\/jamaophthalmology_mccann_2023_rv_230001_1705526199.4634.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:01:17Z","timestamp":1705593677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2812947"}},"subtitle":["An Overview of Systematic Reviews"],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.5751","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}